Mobile health Network Solutions Dossier
Qualitative Analysis
Business overview
Mobile-health Network Solutions (NASDAQ: MNDR) is a Singapore-based, AI-enabled digital health platform that provides comprehensive telehealth solutions primarily in Singapore and across Southeast Asia, with an expanding footprint in the United States and other emerging markets. Founded in 2009 and publicly listed on the NASDAQ Capital Market in April 2024, the company operates its flagship MaNaDr platform. MaNaDr is a 360-degree healthcare ecosystem accessible via a mobile application and website, connecting patients with a network of healthcare providers. The platform offers teleconsultation services, prescription fulfillment, medication delivery, health screenings, vaccinations, and corporate wellness solutions (MaNaCare). Additionally, the company engages in wholesale pharmaceutical distribution to clinics (MaNaPharma) and e-commerce sales of healthcare products (MaNaShop/MaNaStore).
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Transitioning to secure high-density AI computing capacity by acquiring PP Grid Sdn. Bhd. and constructing a phased 60 MW AI data center campus in Sarawak, Malaysia.
Expected impact: Reduces long-term costs for the AI-powered health ecosystem while enabling new services like Token as a Service (TaaS) and Healthcare Platform as a Service (APaaS).
Partnering under a non-binding Letter of Memorandum with White Group Pte. Ltd. to facilitate up to $100 million in private equity funding from a U.S.-based fund.
Expected impact: Supports the launch and scaling of healthcare technology operations, including sports health physiotherapy and treatment programs for elite athletes.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
To acquire high-density artificial intelligence (AI) data center assets and development rights in Sarawak, Malaysia, securing critical computing capacity for the company's digital health ecosystem.
Financial impact: Accompanied by a MYR 500 million capital injection from the seller in exchange for a 65% equity stake in MNDR.
Strategic Partnerships
Hector Capital will invest up to US$119 million to support MNDR's acquisition of majority stakes in MILVIK Singapore (BIMA) and M&M Helix, expanding MNDR's AI-powered healthcare solutions across Asia and Africa.
Terms: Investment of up to US$119 million via equity subscription, convertible instruments, or other financial structures.
Strategic equity investment to finance the planned acquisition of Lifepack, a leading digital pharmacy platform in Indonesia, and support broader market entry across Southeast Asia.
Terms: US$900,000 subscription for Class A ordinary shares priced at US$1.80 each.
To launch and operate MNDR's AI-powered digital health platform in the Republic of Ghana, combining MNDR's technology with Jospong's local presence.
Terms: Terms to be finalized in definitive agreements.